H2 2025 Earnings
Financial report interval: 2025.07.01 - 2025.12.31
Overview: SIHUAN PHARM(00460) the Revenue is 1.637 B (--%), Beat estimate;the EBIT is 381.14 M (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.64B--
1.30B--
+0.33B--%
EBITExceed expectations
0.38B--
0.18B--
+0.20B--%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf